Zepp Health ZEPP Income Statement (2016-2026)

NYSE ZEPP
$5.09 +0.10 (+2.00%)
At close: Aug 25, 2026 · 4:00 PM EDT
Reported Financials

Zepp Health Quarterly Income Statement

Periods 38 quarters
Latest Mar 2026

Zepp Health reported revenue of $51.55M and net income of -$19.64M for the quarter ended Mar 2026, up 33.8% year over year. This income statement covers 38 quarters of results from Dec 2016 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue
284.23M249.26M260.75M119.42M165.46M169.51M155.39M93.95M92.45M83.11M83.01M39.96M40.64M42.46M59.54M38.54M59.41M75.79M85.17M51.55M
Cost of RevenueCost of Rev
221.81M199.01M210.43M95.41M135.85M137.08M123.22M78.97M72.12M54.94M54.17M25.26M24.28M25.22M37.61M24.18M37.91M46.87M50.75M32.11M
Gross Profit
62.42M50.24M50.32M24.02M29.61M32.43M32.16M14.97M20.32M28.17M28.83M14.70M16.36M17.24M21.93M14.36M21.49M28.92M34.41M19.44M
Operating items
Research & DevelopmentR&D
-16.21M-14.08M-23.87M-16.26M-16.16M-17.41M-18.14M-12.52M-10.21M-9.76M-11.98M-10.77M-10.55M-11.90M-13.25M-13.84M-12.05M-12.01M-15.93M-16.64M
Selling, General & AdministrativeSG&A
-10.29M-9.61M-10.15M-9.18M-10.70M-7.41M-7.74M-7.27M-7.73M-6.67M-5.10M-6.42M-4.85M-7.03M-6.55M-6.52M-4.38M-7.00M-11.38M-7.36M
Other Operating ExpensesOther Opex
77.84M64.23M82.76M-23.07M-19.26M-17.91M-16.58M-17.16M-12.75M-10.32M-11.11M-13.44M-10.82M-10.86M-11.06M-12.38M-11.16M-10.80M-10.98M-13.13M
Operating ExpensesOpex
51.33M40.55M48.74M48.53M-46.12M-42.73M-42.45M-36.95M-30.71M-26.79M-28.21M-30.61M-26.23M-29.78M-30.87M-32.74M-27.59M-29.81M-38.29M-37.13M
Operating IncomeOp. Inc
11.09M9.70M1.58M-24.52M-16.77M-10.71M-9.98M-21.97M-10.39M1.49M0.75M-15.91M-9.87M-12.54M-8.94M-18.38M-6.10M-0.88M-3.87M-17.69M
EBIT
11.09M9.70M1.58M-24.49M-16.77M-10.71M-9.98M-21.97M-10.33M1.50M0.74M-15.91M-9.87M-12.54M-8.94M-18.38M-6.10M-0.88M-3.87M-17.69M
Non-operating items
Non Operating Investment IncomeNon-Op. Investment Inc.
-0.04M-0.10M
Interest & Investment IncomeInt & Inv Inc
0.70M0.56M0.45M0.40M0.32M0.46M0.63M0.60M0.85M0.81M0.82M1.01M0.95M0.94M0.77M0.58M0.29M0.33M0.32M0.33M
Other Non Operating IncomeOther Non Op Inc.
-0.03M3.67M2.06M0.35M5.59M-0.07M-0.29M-0.11M-0.24M0.12M0.07M0.13M-0.08M-0.77M0.00M0.06M0.32M-0.22M-0.05M
Non Operating IncomeNon Op. Inc.
0.08M-0.04M
Net income details
EBT
13.39M12.35M4.29M-22.25M-14.34M-8.13M-7.01M-19.43M-7.73M3.93M3.01M-13.44M-7.54M-10.31M-6.72M-16.44M-4.56M0.92M-1.93M-15.71M
Tax ProvisionsTaxes
-1.80M-0.97M-0.08M2.64M1.94M4.72M0.35M3.60M1.66M-0.07M-2.77M-0.07M-0.05M-13.57M-0.11M-0.24M-0.12M-2.07M-0.21M
Profit After TaxPAT
14.30M7.62M5.67M-14.02M-15.97M-2.40M-10.96M-19.94M-10.07M0.29M-1.26M-14.80M-10.85M-13.26M-36.90M-19.74M-7.74M-1.62M-10.97M-19.64M
Investment IncomeInv. Income
Income from Non-Controlling InterestsInc. Minority
-0.04M-0.04M-0.03M-0.02M-0.04M-0.02M-0.03M-0.03M-0.03M-0.03M0.01M-0.03M-0.01M-0.01M-0.03M
Income from Continuing OperationsIncome (Continuing)
15.19M13.31M4.37M-24.89M-16.29M-12.85M-7.36M-23.04M-9.38M3.99M5.80M-13.37M-7.50M-10.31M6.85M-16.33M-4.32M1.04M0.14M-15.49M
Income from Discontinued OperationsIncome (Discontinued)
Consolidated Net IncomeConsol Net Inc.
15.19M13.31M4.37M-24.89M-16.29M-12.85M-7.36M-23.04M-9.38M3.99M5.80M-13.37M-7.50M-10.31M6.85M-16.33M-4.32M1.04M0.14M-15.49M
Income towards Parent CompanyParent Net Inc
0.050.030.02-24.89M-16.29M-0.01-7.36M-23.04M-9.38M0.005.80M-13.37M-7.50M-10.31M6.85M-16.33M-4.32M1.04M0.14M-15.49M
Preferred Dividend PaymentsPref Dividends
Net Income towards Common StockholdersNet Income
0.060.030.02-0.06-0.07-0.01-0.04-0.08-0.040.00-0.01-0.06-0.04-0.05-0.14-16.33M-4.32M1.04M0.14M-15.49M
Additional items
EPS (Basic)
0.000.000.000.000.000.000.000.000.000.000.000.000.000.00-0.06-0.020.000.00-0.06
EPS (Diluted)
0.000.000.000.000.000.000.000.000.000.000.000.000.000.00-0.06-0.020.000.00-0.06
Shares Outstanding
62.95M63.12M63.04M62.38M61.43M61.28M61.57M61.28M60.99M60.79M60.78M64.88M65.10M258.39M258.88M256.41M254.97M253.10M254.43M253.93M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
88.0048.0066.09M62.38M61.90M61.69M61.57M61.28M60.99M64.04M60.78M64.88M65.10M258.39M258.88M258.88M258.88M258.88M254.43M254.43M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
0.63M0.63M0.63M0.62M0.61M0.61M0.62M0.61M0.61M0.61M0.61M16.22M65.10M16.15M16.35M16.03M15.94M15.82M16.92M15.87M
EBITDA
11.09M9.70M1.58M-24.49M-16.77M-10.71M-9.98M-21.97M-10.33M1.50M0.74M-15.91M-9.87M-12.54M-8.94M-18.38M-6.10M-0.88M-3.87M-17.69M
Interest ExpensesInt Expense
-1.60M-2.09M-2.26M-1.84M-2.11M-2.12M-2.34M-1.94M-1.76M-1.61M-1.44M-1.44M-1.37M-1.29M-1.45M-1.36M-1.25M-1.48M-1.62M-1.65M
Tax Rate
-13.43%-7.83%-1.87%-11.87%-13.55%-58.11%-5.03%-18.54%-21.44%-1.68%-92.13%0.54%0.62%201.99%0.67%5.31%-12.69%106.98%1.36%